SCHEMBL2501715

SCHEMBL2501715

O[n+]1c2ccccc2nc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.50
ALDH1A1 P00352 7/20 0.42
HPGD P15428 3/20 0.42
GLA P06280 2/20 0.42
ACHE P22303 2/20 0.42
NQO2 P16083 4/20 0.40
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
KEAP1 Q14145 1/20 0.39
NFE2L2 Q16236 1/20 0.39
KMT2A Q03164 5/20 0.38
RAB9A P51151 4/20 0.38
GAA P10253 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
KDM4E B2RXH2 4/20 0.37
MEN1 O00255 4/20 0.37
NPC1 O15118 4/20 0.37
POLB P06746 4/20 0.37
HSD17B10 Q99714 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL51330 0.74 CRHBP (0.61) MAPTALDH1A1HPGDGLAACHE
SCHEMBL9813311 0.74 MAPT (0.50) MAPTALDH1A1HPGDGLAACHE
SCHEMBL232685 0.74 POLB (0.58) MAPTALDH1A1HPGDGLAACHE
SCHEMBL9229574 0.74 MAPT (0.50) MAPTALDH1A1HPGDGLAACHE
SCHEMBL29359446 0.74 CRHBP (0.61) MAPTALDH1A1HPGDGLAACHE
SCHEMBL17187704 0.74 MAPT (0.50) MAPTALDH1A1HPGDGLAACHE
SCHEMBL8165959 0.70 BLM (0.53) MAPTALDH1A1HPGDGLAACHE
Hydrochloric Acid SCHEMBL14871697 0.70 MAPT (0.46) MAPTALDH1A1HPGDGLAACHE
SCHEMBL1264191 0.70 MAPT (0.46) MAPTALDH1A1HPGDGLAACHE
Phenazine SCHEMBL182948 0.70 MAPT (0.85) MAPTALDH1A1HPGDGLAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637658-B2 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC (US) 2014-01-28 US disclosed
US-20130123475-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays Life Technologies Corporation (US) 2013-05-16 US disclosed
US-20120220751-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays Life Technologies Corporation (US) 2012-08-30 US disclosed
US-20110245462-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays Life Technologies Corporation (US) 2011-10-06 US disclosed
US-20090105452-A1 NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS APPLERA CORPORATION (US) 2009-04-23 US disclosed
US-20050164225-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2005-07-28 US disclosed
US-20040005607-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2004-01-08 US disclosed
US-20030082547-A1 Non-fluorescent quencher compounds and biomolecular assays APPLIED BIOSYSTEMS, LLC 2003-05-01 US disclosed
WO-2003019145-A2 NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS APPLERA CORPORATION (US) 2003-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050164225-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MAPT 4274/4885ALDH1A1 3999/4885HPGD 2875/4885
US-20130123475-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885HPGD 2805/4885
US-20030082547-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MAPT 4380/4885ALDH1A1 3285/4885HPGD 2905/4885
US-20090105452-A1 NON-FLUORESCENT QUENCHER COMPOUNDS AND BIOMOLECULAR ASSAYS DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885HPGD 2805/4885
US-20040005607-A1 Non-fluorescent quencher compounds and biomolecular assays DNTT, PNP, NT5C2 MAPT 4380/4885ALDH1A1 3285/4885HPGD 2905/4885
US-20110245462-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885HPGD 2805/4885
US-20120220751-A1 Non-Fluorescent Quencher Compounds and Biomolecular Assays DNTT, PNP, NT5C2 MAPT 4230/4885ALDH1A1 3969/4885HPGD 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.